Liquid Biopsies in Head and Neck Cancer: Current State and Future Challenges
Head and neck cancers are the seventh most frequent malignancy worldwide, consisting of a heterogeneous group of cancers that develop in the oral cavity, pharynx, and larynx, with head and neck squamous cell carcinoma (HNSCC) being the most common pathology. Due to limitations with screening and phy...
Main Authors: | Lingyi Kong, Andrew C. Birkeland |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/8/1874 |
Similar Items
-
Liquid Biopsy in Head and Neck Cancer: Promises and Challenges
by: Nonaka, T., et al.
Published: (2018) -
A Pilot Study to Non-Invasively Track PIK3CA Mutation in Head and Neck Cancer
by: Henri Schmidt, et al.
Published: (2018-11-01) -
Evaluation of therapeutic efficacy with CytoSorter® circulating tumor cell–capture system in patients with locally advanced head and neck squamous cell carcinoma
by: Zheng W, et al.
Published: (2019-06-01) -
Head and neck cancer: searching for genomic and epigenetic biomarkers in body fluids – the state of art
by: Ilda Patrícia Ribeiro, et al.
Published: (2019-07-01) -
Circulating Tumour Cell Biomarkers in Head and Neck Cancer: Current Progress and Future Prospects
by: Karl Payne, et al.
Published: (2019-08-01)